Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,906.00 2.50 (0.13%)

Bid:

1,904.50

Ask:

1,905.50

Spread: 1.00 (0.053%)

Market Cap: £76.41b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

AstraZeneca raises profit outlook on strong medicines demand

Expects 2024 sales and profit to grow by a mid teens percentage *

UK earnings, trading statements calendar - next 7 days

GSK announces promising trial data for ViiV Healthcare HIV drugs

(Alliance News) - GSK PLC on Tuesday reported "positive" data for testing on three different treatments by ViiV Healthcare, its majority-owned special...

Robitussin maker settles lawsuit in US over 'non-drowsy' claim

NEW YORK, July 22 (Reuters) - The maker of Robitussin settled a consumer lawsuit that claimed its "non-drowsy" cough and flu medicine causes drowsin...

London close: Stocks fall on day of global IT chaos

(Sharecast News) - London's stock markets closed in the red on Friday, affected by a significant global IT outage and a drop in UK retail sales.

GSK application for myeloma treatment accepted by EMA

(Sharecast News) - GSK announced on Friday that the European Medicines Agency (EMA) has accepted its marketing authorisation application for 'Blenrep'...

LONDON MARKET OPEN: Stocks suffer on underwhelming local data

(Alliance News) - The FTSE 100 opened higher in London on Friday morning, while other stocks remained downbeat, as a nationwide tech outage combined w...

GSK drug for multiple myeloma accepted for European regulatory review

(Alliance News) - GSK PLC on Friday said its treatment for relapsed or refractory multiple myeloma has been accepted for review by a European regulato...